People with HIV have altered levels of a specific RNA molecule related to both aging and inflammation. This molecule remains altered even with antiretroviral treatment, indicating that their immune system remains affected despite receiving antiretroviral treatment and controlling the infection. The authors of the study, published in the Journal of Microbiology, Immunology, and Infection, suggest that the origin of this alteration is chronic inflammation caused by the infection, regardless of the treatment received by patients. Having this marker can be helpful in monitoring the evolution of patients and the effectiveness of the drugs they take to restore the normal functioning of their immune system.
The Lancet Public Health journal has published the results of one of the largest and most up-to-date studies worldwide to evaluate the point prevalence of clinically relevant depressive symptoms.
14/06/2023 - General information
The Epidemiology and Public Health Program (EPISAP) of the Hospital del Mar Research Institute held its annual meeting on June 7, where the strategic research lines of the groups were shared and the strengths of the program were analyzed. It is worth mentioning the participation in the program of young talented researchers. A consolidated research trajectory together with emerging lines, such as those derived from the COVID-19 pandemic, were highlighted at the meeting. Funding has been received for European projects in areas such as personalized prevention of suicide and depression, measurement of patient reported outcomes (PROs) and the impact on occupational health and safety associated with digital platforms.
Més informació "Annual Meeting of the Epidemiology and Public Health Program"
18/05/2023 - General information
The PROMES-U project aims to improve the mental health of undergraduate students by analyzing the factors that may influence the onset of mental health problems, as well as the implementation and evaluation of online interventions for the promotion of mental health and the prevention of depression and anxiety problems. Follow-up data collection began last May 4 among students who filled out the baseline survey just one year ago, with an email being sent to those who gave up their email address. Upon completion of the questionnaire, they receive a personalized report on their mental health, as well as recommendations on healthy habits and available resources. The data collected will help to improve knowledge about the mental health of students at the university.
Més informació "Data collection is started with the PROMES-U follow-up questionnaire."
18/11/2022 - General information
A team of researchers from the Hospital del Mar Medical Research Institute has created a model for predicting individual breast cancer risk that could be used to create personalised breast cancer screening strategies. The research, presented at the 13th European Breast Cancer Conference, could make breast screening programmes more effective and ultimately improve survival rates. It could also mean fewer people suffering from 'false positives' (when screening tests indicate cancer, but other tests show there is none) and 'overdiagnosis' (when people are diagnosed and treated for a cancer that is extremely slow growing and has not caused any problems in their lives).
28/10/2022 - General information
This is a study cohort comprising 200,000 people, which will be used to study and improve the health of the Spanish population. Dr. Jordi Alonso, head of the Health Services Research Group at the IMIM-Hospital del Mar, is a member of the project's executive committee, which has just completed its first year of work. The Hospital del Mar Medical Research Institute is one of the 21 Spanish institutions that, together with the National Statistics Institute (INE), form part of the IMPaCT Cohort project. This initiative is aimed at creating a cohort of 200,000 people over the age of fifteen and using them to study and improve the health of the population. The project has been running for a year, and a meeting was held at the end of September, in Alcalá de Henares, to analyse its progress.
27/10/2022 - General information
On the occasion of the Pharmacist's Day, last October 18, the Barcelona College of Pharmacists awarded the Prize for the best community project in the CARGENCORS Study: Cardiovascular Genetic risk score for Risk Stratification of patients positive for the SARS-CoV-2 (COVID-19) virus, led by researchers and physicians from the Hospital del Mar Medical Research Institute (IMIM), the Institute of Biomedical Research of Girona. Josep Trueta (IDIBGI), the University Institute for Primary Care Research (IDIAP Jordi Gol) and the University of Vic-Central University of Catalonia.
Més informació "The College of Pharmacists of Barcelona awards the CARGENCORS study"
17/08/2022 - General information
A joint research project from the Hospital del Mar Medical Research Institute and the CNIC has been selected to receive a grant from the Carlos III Health Institute to analyse whether a greater presence of omega-3 in the blood is associated with a brain that is more resistant to this neurodegenerative disease. The research project led by Dr. Aleix Sala-Vila, from the Cardiovascular Risk and Nutrition Research Group at IMIM-Hospital del Mar has received one of the research, development and innovation project grants from the Carlos III Health Institute. The study will be carried out in conjunction with the National Centre for Cardiovascular Research Carlos III (CNIC) as part of the PESA study that this institute is developing with Banco Santander. The initiative will receive 114,000 euros in funding.
Més informació "Research into whether a diet rich in omega-3 helps prevent Alzheimer's disease"
28/06/2022 - General information
This is a study on the impact of the COVID-19 pandemic on the breast cancer screening program. Its main author is Dr. Guillem Bosch, resident physician of the PSMAR-UPF-ASPB Teaching Unit and member of the Health Services Research Group of the Hospital del Mar Medical Research Institute.
14/06/2022 - General information
It is published by Triacastela Publishing House. In it, Dr. Porta explains, in an easy and entertaining way, current epidemiological and public health issues, such as the management by governments of the COVID-19 pandemic. Epidemiology and epidemiologists have been in vogue over the last two years, when SARS-CoV-2 and COVID-19 have made all the headlines. A medical and scientific discipline that studies and acts on populations and groups of people under real conditions, which is carried out outside laboratories.
Més informació "Epidemiología cercana, the new book by Dr. Miquel Porta"
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
